Filing Details

Accession Number:
0000899243-22-029840
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-26 16:06:10
Reporting Period:
2022-08-24
Accepted Time:
2022-08-26 16:06:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1796129 Vincerx Pharma Inc. VINC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1376260 P. Christopher Lowe 260 Sheridan Avenue, Suite 400
Palo Alto CA 94306
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-08-24 18,400 $1.65 28,400 No 4 P Direct
Common Stock Acquisiton 2022-08-25 11,600 $1.65 40,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. Represents a weighted average purchase price. Actual purchase prices ranged from $1.638 to $1.649 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares purchased within the range indicated.
  2. Represents a weighted average purchase price. Actual purchase prices ranged from $1.6499 to $1.65 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares purchased within the range indicated.